Literature DB >> 2372043

Cellular localization of type I III and IV procollagen gene transcripts in normal and fibrotic human liver.

S Milani1, H Herbst, D Schuppan, C Surrenti, E O Riecken, H Stein.   

Abstract

The authors have determined the cell types producing alpha 1 (I), alpha 2 (I), alpha 1 (III), and alpha 1 (IV) procollagen gene transcripts in adult human liver by in situ hybridization with [35S]-labeled RNA probes. The liver specimens comprised a total of 20 biopsies with normal histology and biopsies with fibrosis or cirrhosis at different clinical stages and of heterogeneous origins. In normal liver, procollagen type I, III, and IV transcripts were detected in stromal and vascular mesenchymal cells of portal tracts and central veins, as well as in some perisinusoidal cells of the lobule. In fibrotic liver, increased levels of these procollagen mRNAs were observed in the same locations, and particularly enhanced in stromal cells of fibrotic septa and portal tracts, as well as in perisinusoidal cells. Expression of alpha 1 (IV) procollagen RNA was additionally found in some vascular endothelial and bile duct epithelial cells. Although previously suggested as the major source of liver collagens, hepatocytes showed no significant procollagen transcript levels in any of our samples. Thus, procollagen synthesis does not appear to be a function of hepatocytes, but rather of mesenchymal, endothelial, and bile duct epithelial cells in adult human liver. These findings may have implications for the development of specifically targeted antifibrotic therapies.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2372043      PMCID: PMC1877702     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  38 in total

Review 1.  Structure of the extracellular matrix in normal and fibrotic liver: collagens and glycoproteins.

Authors:  D Schuppan
Journal:  Semin Liver Dis       Date:  1990-02       Impact factor: 6.115

Review 2.  Pathology of alcoholic liver diseases.

Authors:  H Popper; S N Thung; M A Gerber
Journal:  Semin Liver Dis       Date:  1981-08       Impact factor: 6.115

3.  Collagen formation by the hepatocyte in primary monolayer culture and in vivo.

Authors:  R F Diegelmann; P S Guzelian; R Gay; S Gay
Journal:  Science       Date:  1983-03-18       Impact factor: 47.728

4.  Collagen production by rat hepatocytes and sinusoidal cells in primary monolayer culture.

Authors:  S C Tseng; P C Lee; P F Ells; D M Bissell; E A Smuckler; R Stern
Journal:  Hepatology       Date:  1982 Jan-Feb       Impact factor: 17.425

5.  Nucleotide sequence of cloned rat serum albumin messenger RNA.

Authors:  T D Sargent; M Yang; J Bonner
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

6.  Purified rat liver fat-storing cells in culture divide and contain collagen.

Authors:  A M de Leeuw; S P McCarthy; A Geerts; D L Knook
Journal:  Hepatology       Date:  1984 May-Jun       Impact factor: 17.425

7.  Alcoholic liver injury in baboons: transformation of lipocytes to transitional cells.

Authors:  K M Mak; M A Leo; C S Lieber
Journal:  Gastroenterology       Date:  1984-07       Impact factor: 22.682

8.  Vitamin A-containing lipocytes and formation of type III collagen in liver injury.

Authors:  G Kent; S Gay; T Inouye; R Bahu; O T Minick; H Popper
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

9.  Immunocytochemical detection of desmin in fat-storing cells (Ito cells).

Authors:  Y Yokoi; T Namihisa; H Kuroda; I Komatsu; A Miyazaki; S Watanabe; K Usui
Journal:  Hepatology       Date:  1984 Jul-Aug       Impact factor: 17.425

10.  Changes in collagen and albumin mRNA in liver tissue of mice infected with Schistosoma mansoni as determined by in situ hybridization.

Authors:  M A Saber; D A Shafritz; M A Zern
Journal:  J Cell Biol       Date:  1983-10       Impact factor: 10.539

View more
  29 in total

1.  Dynamic changes of type I,III and IV collagen synthesis and distribution of collagen-producing cells in carbon tetrachloride-induced rat liver fibrosis.

Authors:  Wei-Dong Du; Yue-E Zhang; Wei-Rong Zhai; Xiao-Mei Zhou
Journal:  World J Gastroenterol       Date:  1999-10       Impact factor: 5.742

2.  RNA-binding protein RBMS3 is expressed in activated hepatic stellate cells and liver fibrosis and increases expression of transcription factor Prx1.

Authors:  Dillon Fritz; Branko Stefanovic
Journal:  J Mol Biol       Date:  2007-06-09       Impact factor: 5.469

3.  Differential expression of the monocyte chemoattractant protein-1 gene in human papillomavirus-16-infected squamous intraepithelial lesions and squamous cell carcinomas of the cervix uteri.

Authors:  L Riethdorf; S Riethdorf; K Gützlaff; F Prall; T Löning
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

4.  Global gene expression profiling of dimethylnitrosamine-induced liver fibrosis: from pathological and biochemical data to microarray analysis.

Authors:  Li-Jen Su; Shih-Lan Hsu; Jyh-Shyue Yang; Huei-Hun Tseng; Shiu-Feng Huang; Chi-Ying F Huang
Journal:  Gene Expr       Date:  2006

5.  Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis.

Authors:  M Pinzani; S Milani; H Herbst; R DeFranco; C Grappone; A Gentilini; A Caligiuri; G Pellegrini; D V Ngo; R G Romanelli; P Gentilini
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

Review 6.  Hepatic fibrosis--current concepts of pathogenesis and therapy.

Authors:  B Högemann; W Domschke
Journal:  Gastroenterol Jpn       Date:  1993-08

7.  High-level expression and characterization of bioactive human truncated variant of hepatocyte growth factor in Escherichia coli.

Authors:  Xiaohua Wang; Haifeng Liu; Zhongmin Zhang; Yang Liu; Yuting Li; Jinqiu Gui; Yanhui Chu
Journal:  World J Microbiol Biotechnol       Date:  2014-08-14       Impact factor: 3.312

Review 8.  Alcohol metabolites and lipopolysaccharide: roles in the development and/or progression of alcoholic liver disease.

Authors:  Courtney S Schaffert; Michael J Duryee; Carlos D Hunter; Bartlett C Hamilton; Amy L DeVeney; Mary M Huerter; Lynell W Klassen; Geoffrey M Thiele
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

9.  Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression.

Authors:  Eleonora Patsenker; Yury Popov; Felix Stickel; Alfred Jonczyk; Simon L Goodman; Detlef Schuppan
Journal:  Gastroenterology       Date:  2008-04-16       Impact factor: 22.682

10.  Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease.

Authors:  S Milani; H Herbst; D Schuppan; H Stein; C Surrenti
Journal:  Am J Pathol       Date:  1991-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.